Short-Term COVID-19 Outcomes Worse in SLE, Lupus Nephritis
Patients with lupus nephritis should be allow early access to COVID-19 vaccination, according to investigators.
All articles by Natasha Persaud
Nephrologists and Rheumatologists View Lupus Nephritis Treatment Options Differently
In a survey, more rheumatologists than nephrologists viewed belimumab and voclosporin as a “substantial advance” in lupus nephritis treatment.
Belimumab Effective in Relapsed and Newly Diagnosed Lupus Nephritis
Standard therapy for lupus nephritis achieves complete renal response in only 20% to 40% of patients.
Voclosporin Demonstrates Efficacy in Severe Lupus Nephritis
Voclosporin acts as an anti-inflammatory agent and also stabilizes podocytes to reduce proteinuria.
Belimumab Shows Efficacy in Real-World Lupus Nephritis Population
Renal response at 6 months strongly predicted belimumab’s durability.
Belimumab May Help Preserve Kidney Function in Lupus Nephritis
The risk of lupus nephritis flares decreased with belimumab treatment, investigators reported.
Developments in Lupus Nephritis Management Are Promising
Recent approval of new drugs for lupus nephritis and promising therapies on the horizon bode well for the care of patients with the kidney disorder.
KDIGO Releases Updated Guidelines for Lupus Nephritis and Other Glomerular Diseases
The management recommendations for lupus nephritis are poised to change significantly in the coming months, a KDIGO committee revealed.
Race-Free GFR Equations Based on Creatinine Plus Cystatin C More Accurate
The current guideline-recommended creatinine-based eGFR equation incorporates a race coefficient that may overestimate eGFR in Black adults and contribute to discordant care.
Urate-Lowering Therapies for Hyperuricemia in CKD Not Renoprotective
Investigators examined the urate-lowering effects of febuxostat, allopurinol, and benzbromarone and their association with renal protection in CKD.
- Loading...
Loading...
Loading... 
Loading...